SD49-7

1 1

Selleck Chemicals

E1335-5MG

€144,00 EUR
€144,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

SD49-7 is an inhibitor linked to Epigenetic Regulation and related pathway-oriented research. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to chromatin-state control, histone modification, and transcriptional regulation in cancer and epigenetics models.

The pathway annotation connects SD49-7 to Epigenetic Regulation, supporting experiments that monitor chromatin-state control, histone modification, and transcriptional regulation across biochemical, cellular, or phenotypic assay formats. This context is compatible with chromatin, histone-mark, and gene-expression profiling, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In cancer and epigenetics models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Pathway perturbation studies connected to Epigenetic Regulation
  • Concentration-response inhibition and target-dependence studies
  • Phenotypic profiling in cancer and epigenetics models
  • Combination studies with orthogonal perturbagens

Overall, SD49-7 is well suited to pathway-oriented studies that need a defined compound input for Epigenetic Regulation readouts in cancer and epigenetics models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Pathways:
Epigenetic Regulation
Research Area:
Cancer • Epigenetics
CAS No.:
54009-54-0
Molecular Weight:
306.32
Formula:
C₁₈H₁₄N₂O₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.